Literature DB >> 26937148

Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.

Hai-Jie Hu1, Hui Mao1, Anuj Shrestha1, Yong-Qiong Tan1, Wen-Jie Ma1, Qin Yang1, Jun-Ke Wang1, Nan-Sheng Cheng1, Fu-Yu Li1.   

Abstract

AIM: To evaluate the prognostic factors of hilar cholangiocarcinoma in a large series of patients in a single institution.
METHODS: Eight hundred and fourteen patients with a diagnosis of hilar cholangiocarcinoma that were evaluated and treated between 1990 and 2014, of which 381 patients underwent curative surgery, were included in this study. Potential factors associated with overall survival (OS) and disease-free survival (DFS) were evaluated by univariate and multivariate analyses.
RESULTS: Curative surgery provided the best long-term survival with a median OS of 26.3 mo. The median DFS was 18.1 mo. Multivariate analysis showed that patients with tumor size > 3 cm [hazard ratio (HR) = 1.482, 95%CI: 1.127-1.949; P = 0.005], positive nodal disease (HR = 1.701, 95%CI: 1.346-2.149; P < 0.001), poor differentiation (HR = 2.535, 95%CI: 1.839-3.493; P < 0.001), vascular invasion (HR = 1.542, 95%CI: 1.082-2.197; P = 0.017), and positive margins (HR = 1.798, 95%CI: 1.314-2.461; P < 0.001) had poor OS outcome. The independent factors for DFS were positive nodal disease (HR = 3.383, 95%CI: 2.633-4.348; P < 0.001), poor differentiation (HR = 2.774, 95%CI: 2.012-3.823; P < 0.001), vascular invasion (HR = 2.136, 95%CI: 1.658-3.236; P < 0.001), and positive margins (HR = 1.835, 95%CI: 1.256-2.679; P < 0.001). Multiple logistic regression analysis showed that caudate lobectomy [odds ratio (OR) = 9.771, 95%CI: 4.672-20.433; P < 0.001], tumor diameter (OR = 3.772, 95%CI: 1.914-7.434; P < 0.001), surgical procedures (OR = 10.236, 95%CI: 4.738-22.116; P < 0.001), American Joint Committee On Cancer T stage (OR = 2.010, 95%CI: 1.043-3.870; P = 0.037), and vascular invasion (OR = 2.278, 95%CI: 0.997-5.207; P = 0.051) were independently associated with tumor-free margin, and surgical procedures could indirectly affect survival outcome by influencing the tumor resection margin.
CONCLUSION: Tumor margin, tumor differentiation, vascular invasion, and lymph node status were independent factors for OS and DFS. Surgical procedures can indirectly affect survival outcome by influencing the tumor resection margin.

Entities:  

Keywords:  Hilar cholangiocarcinoma; Prognosis; Surgical outcome; Survival; Tumor-free margin

Mesh:

Year:  2016        PMID: 26937148      PMCID: PMC4768206          DOI: 10.3748/wjg.v22.i8.2601

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Surgery for hepatocellular carcinoma located in the caudate lobe.

Authors:  Masahiko Sakoda; Shinichi Ueno; Fumitake Kubo; Kiyokazu Hiwatashi; Taro Tateno; Hiroshi Kurahara; Yuukou Mataki; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

2.  Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma.

Authors:  A Kobayashi; S Miwa; T Nakata; S Miyagawa
Journal:  Br J Surg       Date:  2010-01       Impact factor: 6.939

3.  Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV.

Authors:  Q-B Cheng; B Yi; J-H Wang; X-Q Jiang; X-J Luo; C Liu; R-Z Ran; P-N Yan; B-H Zhang
Journal:  Eur J Surg Oncol       Date:  2012-09-16       Impact factor: 4.424

Review 4.  Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach.

Authors:  K D Lillemoe; J L Cameron
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

5.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

6.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

7.  Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Authors:  Peter Neuhaus; Sven Jonas; Utz Settmacher; Armin Thelen; Christoph Benckert; Enrique Lopez-Hänninen; Rainer E Hintze
Journal:  Langenbecks Arch Surg       Date:  2003-06-18       Impact factor: 3.445

Review 8.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

9.  Isolated caudate lobe resection: technical challenges.

Authors:  Sastha Ahanatha Pillai; Jeswanth Sathyanesan; Senthilkumar Perumal; Srinivasan Ulagendra Perumal; Anand Lakshmanan; Sukumar Ramaswami; Ravi Ramasamy; Ravichandran Palaniappan; Surendran Rajagopal
Journal:  Ann Gastroenterol       Date:  2013

10.  Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients.

Authors:  Anthony T Ruys; Steven van Haelst; Olivier R Busch; Erik A Rauws; Dirk J Gouma; Thomas M van Gulik
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

View more
  25 in total

1.  Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required?

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Anuj Shrestha; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-03-06       Impact factor: 3.452

2.  Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Masayuki Akita; Tetsuo Ajiki; Taku Matsumoto; Kenta Shinozaki; Tadahiro Goto; Sadaki Asari; Hirochika Toyama; Masahiro Kido; Takumi Fukumoto; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2017-03-13       Impact factor: 3.452

3.  The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.

Authors:  Xi-Wen Ye; Hai-Jie Hu; Xian-Ze Xiong; Jiong Lu; Nan-Sheng Cheng
Journal:  Surg Today       Date:  2021-03-02       Impact factor: 2.549

4.  Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Ke Wang; Chen-Yu Jiao; Zi-Cheng Shao; Xiang-Cheng Li
Journal:  J Gastrointest Surg       Date:  2017-02-06       Impact factor: 3.452

5.  Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis.

Authors:  Richard W D Gilbert; Tori Lenet; Sean P Cleary; Rory Smoot; Ching-Wei D Tzeng; Flavio G Rocha; Guillaume Martel; Kimberly A Bertens
Journal:  Ann Surg Oncol       Date:  2022-06-15       Impact factor: 4.339

6.  Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-08-03       Impact factor: 3.452

Review 7.  A review of systemic therapy in biliary tract carcinoma.

Authors:  Holger Jansen; Ulrich-Frank Pape; Nalân Utku
Journal:  J Gastrointest Oncol       Date:  2020-08

8.  Predictors of postoperative early recurrence of extrahepatic bile duct cancer.

Authors:  Masayuki Akita; Tetsuo Ajiki; Kimihiko Ueno; Daisuke Tsugawa; Yu Hashimoto; Motofumi Tanaka; Masahiro Kido; Hirochika Toyama; Takumi Fukumoto
Journal:  Surg Today       Date:  2019-09-23       Impact factor: 2.549

9.  Effectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma.

Authors:  Wen-Jie Ma; Zhen-Ru Wu; Anuj Shrestha; Qin Yang; Hai-Jie Hu; Jun-Ke Wang; Fei Liu; Rong-Xing Zhou; Quan-Sheng Li; Fu-Yu Li
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

Review 10.  The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Lei Liang; Chao Li; Ming-Da Wang; Hao Xing; Yong-Kang Diao; Hang-Dong Jia; Wan Yee Lau; Timothy M Pawlik; Cheng-Wu Zhang; Feng Shen; Dong-Sheng Huang; Tian Yang
Journal:  Int J Clin Oncol       Date:  2021-06-23       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.